Bristol Myers Squibb invests in Series B funding of NeoPhore Ltd.
Client(s) Bristol-Myers Squibb Company
Jones Day advised Bristol Myers Squibb (NYSE: BMY) regarding investing in the Series B funding of NeoPhore Ltd.
Client(s) Bristol-Myers Squibb Company
Jones Day advised Bristol Myers Squibb (NYSE: BMY) regarding investing in the Series B funding of NeoPhore Ltd.